- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Nilogen Oncosystems
Total 710 results
-
Philogen S.p.A.Terminated
-
Philogen S.p.A.Active, not recruiting
-
Philogen S.p.A.CompletedAdvanced Solid Tumors Amenable to Anthracycline Therapy | Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline TherapyGermany, Italy
-
Mologen AGUnknownMetastatic Colorectal CancerFrance, Spain, Germany, United Kingdom, Italy, Belgium, Austria, Estonia
-
Mologen AGCompletedStage IV Renal Cell CancerGermany
-
Philogen S.p.A.CompletedMalignant MelanomaAustria, Germany
-
Philogen S.p.A.CompletedBrain Metastases From Solid TumorsItaly, United Kingdom
-
Philogen S.p.A.TerminatedPatients With CancerItaly, United Kingdom
-
Philogen S.p.A.Not yet recruiting
-
Philogen S.p.A.RecruitingSoft Tissue SarcomaFrance, Spain, Germany, Italy, Poland
-
Philogen S.p.A.RecruitingCarcinoma, Basal Cell | Carcinoma, Cutaneous Squamous CellGermany, Poland, Switzerland
-
Philogen S.p.A.RecruitingLeiomyosarcomaUnited States
-
Philogen S.p.A.RecruitingMalignant MelanomaItaly, France, Germany, Poland
-
Philogen S.p.A.Completed
-
Philogen S.p.A.CompletedRheumatoid ArthritisItaly
-
Mologen AGCompleted
-
Philogen S.p.A.TerminatedBreast Cancer | Advanced Solid TumorItaly
-
Nanogen, Inc.Suspended
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
NightstaRx Ltd, a Biogen CompanyCompletedChoroideremiaFinland, United States, Canada, Denmark, Netherlands, Germany, United Kingdom, Brazil, France
-
NightstaRx Ltd, a Biogen CompanyEnrolling by invitationChoroideremia | X-Linked Retinitis PigmentosaUnited States, United Kingdom, Netherlands, Germany, France, Brazil, Canada, Denmark, Finland
-
NightstaRx Ltd, a Biogen CompanyCompletedX-Linked Retinitis PigmentosaUnited States, France, United Kingdom, Finland, Netherlands, Germany, Canada
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
BiogenAbbVieTerminatedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy, United States, Canada, Germany, Puerto Rico
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
Inogen Inc.CompletedNocturnal HypoxemiaUnited States
-
Inogen Inc.CompletedHeart FailureCanada
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
AbbottBiogenTerminated
-
Nivagen Pharmaceuticals Inc.CompletedInternal HemorrhoidsUnited States, India
-
Reata, a wholly owned subsidiary of BiogenTerminatedChronic Kidney Diseases | Autosomal Dominant Polycystic Kidney | Alport SyndromeUnited States, France, Australia, Japan, Spain, Puerto Rico
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetic NephropathyUnited States
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy VolunteersUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited States
-
Reata, a wholly owned subsidiary of BiogenTerminatedAutosomal Dominant Polycystic Kidney | ADPKDUnited States, Spain, United Kingdom, Australia, France, Japan, Germany, Belgium, Czechia, Italy
-
Reata, a wholly owned subsidiary of BiogenTerminatedConnective Tissue Disease-Associated Pulmonary Arterial HypertensionUnited States, Spain, Japan, Australia, United Kingdom, Canada, Germany, Belgium, Argentina, Israel, Mexico, Brazil, Czechia, Netherlands, Philippines
-
Reata, a wholly owned subsidiary of BiogenTerminatedPulmonary HypertensionUnited States, Spain, Australia, United Kingdom, Canada, Belgium, Argentina, Israel, Japan, Philippines, Germany, Mexico, Brazil, Czechia, Netherlands
-
Reata, a wholly owned subsidiary of BiogenCompletedFocal Segmental Glomerulosclerosis | IgA Nephropathy | Autosomal Dominant Polycystic Kidney | CKD Associated With Type 1 DiabetesUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedChronic Kidney DiseasesUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedIdiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Pulmonary Hypertension | Interstitial Lung Disease | Sarcoidosis | Idiopathic Interstitial Pneumonia | Cryptogenic Organizing Pneumonia | Desquamative Interstitial Pneumonia | Respiratory Bronchiolitis Associated Interstitial Lung Disease and other conditionsUnited States, Germany
-
Reata, a wholly owned subsidiary of BiogenTerminatedBrain MetastasesUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenTerminatedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenCompletedAlport SyndromeUnited States, United Kingdom, Japan, Australia, France, Germany, Puerto Rico, Spain